Amgen colorectal cancer therapy gets USFDA nod Ruchika Sharma17 Jan 2025 6:59 AMThe Food and Drug Administration has approved Amgen sotorasib (Lumakras) with panitumumab (Vectibix) for adult patients with KRAS G12C-mutated...
US FDA turns down full approval of Amgen lung cancer drug Lumakras Ruchika Sharma29 Dec 2023 11:00 AMNew Delhi: The U.S. health regulator on Tuesday declined to grant traditional approval to Amgen's Lumakras for treating lung cancer patients with...
FDA Approves First Targeted Therapy for resistant Lung Cancer with specific genetic mutation Hina Zahid29 May 2021 4:30 AMThe U.S. Food and Drug Administration has approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer...
